Skip to main content

US Gov t Awards Schott $1M to Develop Microarray Platform for Pathogen Detection ...

NEW YORK, Feb. 14 (GenomeWeb News) - The US government has allotted $1 million of its defense appropriations bill to Schott North America to develop a microarray-based platform for detecting biological agents, Schott said recently.

 

According to Duryea, Penn.-based Schott NA, the funding was secured through the offices of Congressman Paul Kanjorksi (D-Penn.).  Schott will collaborate with the University of Scranton's Institute of Molecular Biology and Medicine to develop the fully automated and multiplexed microarray platform, the company said.

 

The new platform would be a 96-well microarray, with the potential to screen for up to 2,000 pathogens in each well, Schott said.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.